Invesco NASDAQ Biotech UCITS ETF
Status: Publicly traded
Direct answer
Invesco NASDAQ Biotech UCITS ETF is publicly traded on LSE under the ticker SBIO.L.
This Exchange-Traded Fund (ETF) employs a passive management strategy, with its primary goal being to replicate the comprehensive total return performance of the NASDAQ Biotechnology Index. Investors should note that their net returns will be calculated after the deduction of management fees, operational expenses, and transaction costs.
Can you invest in Invesco NASDAQ Biotech UCITS ETF?
Yes. Invesco NASDAQ Biotech UCITS ETF trades publicly on LSE as SBIO.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Invesco NASDAQ Biotech UCITS ETF
Detailed equity research is provided by MarketSnap.